Radlink, DePuy Synthes sign exclusive worldwide sales agency agreement

Radlink, Inc., an emerging global leader in advanced medical imaging technology, announced today that it has signed an exclusive worldwide sales agency agreement with Johnson & Johnson subsidiary DePuy Synthes Companies. The contractual partnership provides for the exclusive worldwide distribution of Radlink's advanced imaging products, including the revolutionary Galileo Positioning System™ (GPS) featuring Surgeon's Checklist™ software, through DePuy Synthes Companies' sales representatives worldwide.

"Radlink's breakthrough imaging technologies enable orthopedic surgeons to pre-operatively plan and intraoperatively confirm the placement of hip replacement implant components in a way that has not previously been possible," noted Radlink CEO Tom Hacking.

The GPS provides surgeons with real-time intraoperative imaging and navigation and easy-to-follow steps designed to help address key challenges in hip replacement such as component positioning, sizing, leg length and offset restoration for all surgical approaches. The system has the potential to significantly reduce the cost per THA procedure by reducing the time required to take intraoperative images.

Pioneered by orthopedic surgeons Brad Penenberg at Cedars-Sinai Medical Center and Joel Matta at St. John's Health Center, the GPS has been in use since 2012. The GPS and Surgeon's Checklist™ are currently in use in the leading hospitals and medical schools in the U.S. DePuy Synthes Companies' 2,400 sales representatives will deliver Radlink products to more than one hundred thousand hospitals worldwide.

SOURCE Radlink, Inc.